1Kenyon BM,Browne F,D'Amato RJ.Effects of thalidomide and related metabolites in a mouse corneal model of neovasenlarizatiou[J].Exp Eye Res,1997;64(6):971-8. 被引量：1
2Fujita J,Mestre JR,Zeldis JB,et al.Thalidomide and its analogues inhibire iipopolysaccharide-mediated induction of cyclcoxygenase-2[J].Clin Cancer Res,2001 ;7(11):3349-55. 被引量：1
3Weber D.Thalidomide and its derivatives:new promise for multiple myeloma[J].Cancer Control,2003:10(5):375-83. 被引量：1
4Singhal S,gehta J,Desikan R,et al.Antitumor activity of thalidomide in refractory multiple myelouma[J].New Eng Med,1999;341 (21):1565-72. 被引量：1
6Badogie B,Desikan R,Eddleman P,et al.Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide:identification of prognostic factors in a phase 2 study of 169 patients[J].Blood,2001:98(2):492-4. 被引量：1
7[1]Dario C,Altieri CM.Survivin apoptosis an interloper between cell death and cell prolife ration in cancer.Lab Invest,1999,79 (11):1327 被引量：1
8[2]Grabowski P.Prognostic value of nuclear survivin expression in esophageal squamovs cell carcinoma.Br J Cancer,2003,88 (1):115 被引量：1
9[3]Adida C,Crotty PL,McGrath J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.Am J Pathol,1998,152 (1):43 被引量：1
10[4]Okada E,Mural Y,Matsui K,et al.Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients.Cancer Letts,2001,163 (1):109 被引量：1
